IT1170215B - Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta - Google Patents

Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta

Info

Publication number
IT1170215B
IT1170215B IT22856/83A IT2285683A IT1170215B IT 1170215 B IT1170215 B IT 1170215B IT 22856/83 A IT22856/83 A IT 22856/83A IT 2285683 A IT2285683 A IT 2285683A IT 1170215 B IT1170215 B IT 1170215B
Authority
IT
Italy
Prior art keywords
acute renal
states
treatment
pharmaceutical composition
renal insufficiency
Prior art date
Application number
IT22856/83A
Other languages
English (en)
Italian (it)
Other versions
IT8322856A0 (it
Inventor
Vittorio Bonomini
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Priority to IT22856/83A priority Critical patent/IT1170215B/it
Publication of IT8322856A0 publication Critical patent/IT8322856A0/it
Priority to EP84201286A priority patent/EP0137542B1/en
Priority to CH4281/84A priority patent/CH661871A5/it
Priority to AT84201286T priority patent/ATE65696T1/de
Priority to US06/649,069 priority patent/US4649134A/en
Priority to DE19843433329 priority patent/DE3433329A1/de
Priority to JP59191390A priority patent/JPH0647546B2/ja
Priority to BE0/213640A priority patent/BE900563A/fr
Application granted granted Critical
Publication of IT1170215B publication Critical patent/IT1170215B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT22856/83A 1983-09-12 1983-09-12 Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta IT1170215B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT22856/83A IT1170215B (it) 1983-09-12 1983-09-12 Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
EP84201286A EP0137542B1 (en) 1983-09-12 1984-09-07 Use of defibrotide in the treatment of states of acute renal insufficiency
CH4281/84A CH661871A5 (it) 1983-09-12 1984-09-07 Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta.
AT84201286T ATE65696T1 (de) 1983-09-12 1984-09-07 Verwendung von defibrotid bei der behandlung von zustaenden akuter nierenschwaeche.
US06/649,069 US4649134A (en) 1983-09-12 1984-09-10 Pharmaceutical composition containing defibrotide for the treatment of states of acute renal insufficiency
DE19843433329 DE3433329A1 (de) 1983-09-12 1984-09-11 Pharmazeutische zusammensetzung zur behandlung der stadien akuter niereninsuffizienz
JP59191390A JPH0647546B2 (ja) 1983-09-12 1984-09-12 医薬組成物
BE0/213640A BE900563A (fr) 1983-09-12 1984-09-12 Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22856/83A IT1170215B (it) 1983-09-12 1983-09-12 Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta

Publications (2)

Publication Number Publication Date
IT8322856A0 IT8322856A0 (it) 1983-09-12
IT1170215B true IT1170215B (it) 1987-06-03

Family

ID=11201234

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22856/83A IT1170215B (it) 1983-09-12 1983-09-12 Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta

Country Status (8)

Country Link
US (1) US4649134A (enExample)
EP (1) EP0137542B1 (enExample)
JP (1) JPH0647546B2 (enExample)
AT (1) ATE65696T1 (enExample)
BE (1) BE900563A (enExample)
CH (1) CH661871A5 (enExample)
DE (1) DE3433329A1 (enExample)
IT (1) IT1170215B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
US5223609A (en) * 1986-04-17 1993-06-29 Crinos Industria Farmacobiologica S.P.A. Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
US6699985B2 (en) * 1991-08-21 2004-03-02 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
CA2153778C (en) * 1993-01-13 2004-07-06 Arsinur Burcoglu Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
HK1044896A1 (zh) * 1997-04-28 2002-11-08 Burcoglu Arsinur 治疗hiv感染和与之有关的继发感染的方法
EP1325962A1 (en) * 2001-12-17 2003-07-09 Gentium S.p.A. A method for determining the biological activity of defibrotide
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
EP1982722A1 (en) * 2007-04-16 2008-10-22 Gentium S.p.A. Use of oligotide for the treatment of renal diseases
WO2009065171A1 (en) 2007-11-19 2009-05-28 Cochlear Limited Electrode array for a cochlear implant
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
DK2637672T3 (en) 2010-11-12 2018-10-22 Gentium S R L DEFIBROTID FOR USE IN PROPHYLAXY AND / OR TREATMENT OF GRAPHIC VERSUS HOST DISEASE (GVHD)
KR20150044877A (ko) * 2012-06-22 2015-04-27 젠티엄 에스피에이 디파이브로타이드의 생물학적 활성 측정을 위한 유우글로불린에 기초한 방법
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
RU2766143C2 (ru) * 2017-07-26 2022-02-08 Джентиум С.Р.Л. Жидкая композиция дефибротида для лечения и профилактики веноокклюзионной болезни
KR20200121780A (ko) * 2017-08-03 2020-10-26 재즈 파마슈티칼즈 아일랜드 리미티드 높은 농도에서 핵산을 포함하는 제제
BR112020020865A2 (pt) 2018-04-12 2021-01-19 Jazz Pharmaceuticals, Inc. Defibrotida para prevenção e tratamento da síndrome de liberação de citocinas e neurotoxicidade associadas à imunodepleção
US20230086833A1 (en) 2020-04-17 2023-03-23 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
TW202308659A (zh) 2021-05-06 2023-03-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB879622A (en) * 1959-07-13 1961-10-11 Farmaceutici Italia Steroids
DE1202439B (de) * 1959-11-24 1965-10-07 Cediap Centrale De Destributio Verfahren zur Herstellung von Praeparaten mit hohem Gehalt an freien Desoxyribonucleinsaeuren aus Fischmilch
FR2575M (fr) * 1962-03-19 1964-06-08 Cediap Centrale De Distrib D A Procédé de préparation d'un médicament a base d'adn (acide désoxyribonucléique) en milieu vital d'origine et produit nouveau en résultant.
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
US3899481A (en) * 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali

Also Published As

Publication number Publication date
JPS6084224A (ja) 1985-05-13
EP0137542B1 (en) 1991-07-31
DE3433329A1 (de) 1985-03-28
JPH0647546B2 (ja) 1994-06-22
EP0137542A2 (en) 1985-04-17
CH661871A5 (it) 1987-08-31
IT8322856A0 (it) 1983-09-12
EP0137542A3 (en) 1987-09-02
DE3433329C2 (enExample) 1993-07-22
BE900563A (fr) 1985-01-02
US4649134A (en) 1987-03-10
ATE65696T1 (de) 1991-08-15

Similar Documents

Publication Publication Date Title
IT1170215B (it) Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
FR2481703B1 (fr) Acides aminocyclopentane-alcenoiques et leurs esters, leur preparation et utilisation dans des compositions pharmaceutiques
AU3451371A (en) Improvements in or relating to pharmaceutical compositions
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1167123B (it) Benzoazacicloalchilspiro-imidazolidine,procedimento per prepararle e composizioni farmaceutiche che le contengono
IT1104748B (it) Dispositivo per la somministrazione di sostanze medicamentose in particolare ad animali
IL35987A (en) Vitamin a acid amides,their preparation and pharmaceutical compositions containing them
AU472758B2 (en) Improvements in or relating to injectable therapeutic formulations
CA961041A (en) 1-methyl-3-alkoxymethyl-5,5-disub-stituted barbituric acid compounds and therapeutic compositions containing same
IL37013A (en) Basically substituted alkylidene-aminooxyalkyl-carboxylic acid esters,their preparation and pharmaceutical compositions containing them
BE823513A (fr) Composes diaziniques utilisables notamment comme substances actives de medicaments
CA956526A (en) Tool for administering injections to livestock
ES436179A1 (es) Procedimiento para intensificar la eficacia de medicamentos que in vivo o in vitro demuestren una afinidad de enlace a proteinas de la sangre.
ZA718465B (en) Improvements in or relating to pharmaceutical preparations having anaesthetic activity
ZA718463B (en) Improvements in or relating to pharmaceutical preparations having anaesthetic activity
IT1114869B (it) Derivati attivi di metilammina,composizioni terapeutiche che li contengono e procedimenti per preparare i detti derivati e le dette composizioni
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
IT1170361B (it) Cianoguanidine, procedimento per ottenerle e composizioni farmaceutiche che le contengono
IT8122133A0 (it) Composizione farmaceutica di fosfomicina in compresse da succhiare.
DK131601C (da) Doseringsapparat til blandingsbestanddele i tandfyldninger
IE36780B1 (en) New pharmaceutical preparations
IT1291307B1 (it) Composizione farmaceutica atta al trattamento delle patologie neurodegenerative
IT1197654B (it) Fenilossialchil-piperidine,procedimenti per prepararle e composizioni farmaceutiche che le contengono
AU2563771A (en) Processes forthe preparation of dosage units in solid state for medicament
BE810112A (fr) Medicament antineoplasique

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960910